By Counterforce Health Team in Fabrazyme (agalsidase beta) —

How to Get Fabrazyme (Agalsidase Beta) Covered by Humana in Ohio: Prior Authorization Guide & Appeal Scripts

Quick Answer: Getting Fabrazyme Covered by Humana in Ohio

Humana requires prior authorization for Fabrazyme (agalsidase beta) with genetic testing documentation confirming Fabry disease. Submit through Humana's provider portal or call 877-856-5707. If denied, you have 65 days to appeal internally, then 60 days for external review through the Ohio Department of Insurance. First step: gather genetic test results, diagnosis documentation, and failed therapy records before submitting your prior authorization request.

Table of Contents

Why Ohio State Rules Matter

Ohio's insurance regulations provide specific protections for patients needing specialty medications like Fabrazyme. These state rules work alongside Humana's policies to create multiple pathways for coverage approval and appeal.

Key Ohio Protections:

  • Step therapy exemptions for rare disease medications when clinically justified
  • External review rights through independent medical experts within 60 days of final denial
  • Continuity of care requirements during plan transitions
  • Regulated appeal timelines that insurers must follow

For Humana members in Ohio, these protections apply to both Medicare Advantage and Medicaid plans, though specific procedures may vary by line of business.

Prior Authorization Requirements

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Yes, required for all Fabrazyme Humana PA Lists Humana Policy
Genetic Testing Lab results confirming Fabry disease Submit with PA application Ohio Medicaid PA Requirements
Prescriber Type Specialist preferred, but not required Include prescriber credentials Humana Guidelines
Documentation Clinical notes, prior therapies, diagnosis Medical records department Standard PA Process

Step-by-Step: Fastest Path to Approval

  1. Gather Required Documentation (Patient/Clinic)
    • Genetic test results showing pathogenic GLA variant
    • ICD-10 diagnosis code for Fabry disease
    • Records of prior therapies tried and outcomes
    • Current clinical notes from prescribing physician
  2. Submit Prior Authorization (Prescriber)
    • Use Availity Essentials portal for Ohio Medicaid
    • Call 877-856-5707 for assistance
    • Fax to 888-285-1114 if needed
    • Timeline: Submit 5-7 business days before treatment start
  3. Include Medical Necessity Statement (Prescriber)
    • Document why Fabrazyme is clinically appropriate
    • Address any formulary alternatives and why they're unsuitable
    • Reference FDA labeling and treatment guidelines
  4. Track Decision Timeline (Patient/Clinic)
    • Standard decisions: 72 hours for non-urgent
    • Expedited decisions: 24 hours for urgent cases
    • Follow up if no response within stated timeframe
  5. Prepare for Potential Denial (Patient/Clinic)
    • Review denial letter for specific reasons
    • Gather additional documentation if needed
    • Note appeal deadline (65 days from denial date)

Step Therapy Protections

Ohio law provides specific protections against inappropriate step therapy requirements for rare disease medications. Under Ohio Revised Code §3901.83-E, patients can request step therapy exemptions when:

  • Previous therapy failure: You've tried preferred agents and they were ineffective or caused adverse reactions
  • Rare disease indication: Fabry disease qualifies as a rare condition requiring specialized treatment
  • Clinical contraindication: Medical reasons prevent use of step therapy drugs

Requesting a Step Therapy Override

Required Documentation:

  • Physician statement explaining medical necessity
  • Records of failed prior therapies (include specific drugs, dates, outcomes)
  • Clinical rationale for Fabrazyme over alternatives

Timeline: Plans must respond within 72 hours for non-urgent requests, 24 hours for urgent cases.

Tip: When requesting a step therapy exemption, specifically cite Ohio Revised Code §3901.83-E and emphasize that Fabry disease is a rare, progressive condition requiring prompt, appropriate treatment.

Appeals Process & Deadlines

Internal Appeals with Humana

First Level Appeal (Redetermination)

  • Deadline: 65 days from denial notice
  • How to file: Humana member portal or written request
  • Timeline: 30 days for standard, 72 hours for expedited
  • Required: Additional medical evidence, updated physician letter

Expedited Appeals

  • Available when delay could seriously jeopardize health
  • Must be requested by prescriber with clinical justification
  • Decision within 72 hours

External Review Process

If Humana upholds the denial, Ohio residents can request an independent external review through the Ohio Department of Insurance.

External Review Timeline:

  • File within: 60 days of final internal appeal decision
  • Standard review: 30 days for decision
  • Expedited review: 72 hours when health is at serious risk
  • Cost: Free to member

How to Request:

  1. Complete external review form from Ohio Department of Insurance
  2. Submit all relevant medical records and denial letters
  3. Include physician statement supporting medical necessity
  4. Call 800-686-1526 for assistance with filing

The external review is conducted by independent medical experts with expertise in Fabry disease treatment. Their decision is binding on Humana.

Continuity of Care Rights

Ohio law requires health plans to maintain continuity of care for patients on ongoing specialty therapy when transitioning between plans or providers. This is particularly important for Fabrazyme patients switching to Humana from another insurer.

Transition Protections:

  • Bridge coverage: Minimum 30 days of continued coverage
  • Prior authorization honoring: Existing approvals honored during transition
  • Documentation requirements: Provide current therapy records to new plan

Action Steps for Plan Changes:

  1. Notify Humana immediately of ongoing Fabrazyme therapy
  2. Submit transition of care request with current authorization documents
  3. Provide clinical justification for continued therapy
  4. Request expedited review if coverage gap threatens health

Practical Scripts & Templates

Patient Phone Script for Humana

"Hello, I'm calling about prior authorization for Fabrazyme for Fabry disease. My member ID is [ID number]. I have genetic testing confirming my diagnosis and my doctor has submitted the prior authorization. Can you tell me the status and what additional information might be needed? If this is denied, I'd like to understand the appeals process and my rights under Ohio law."

Medical Necessity Letter Template

Key Elements to Include:

  • Patient demographics and Humana member ID
  • Confirmed diagnosis of Fabry disease with genetic testing results
  • Previous therapies attempted and outcomes (include specific failures or intolerances)
  • Clinical rationale for Fabrazyme based on FDA labeling and treatment guidelines
  • Dosing plan (1 mg/kg every 2 weeks via IV infusion)
  • Monitoring plan and expected outcomes
Clinician Corner: Reference specific sections of the FDA prescribing information when documenting medical necessity. Include patient-specific factors that make Fabrazyme the most appropriate treatment choice.

Common Denial Reasons

Denial Reason How to Overturn Documentation Needed
Lack of genetic confirmation Submit genetic test results Lab report showing pathogenic GLA variant
Non-specialist prescriber Provide prescriber credentials Medical license, specialty certification
Insufficient prior therapy trials Document previous treatments Pharmacy records, clinical notes, failure reasons
Not medically necessary Strengthen clinical justification Updated physician letter, guideline references
Formulary alternative available Explain why alternatives unsuitable Clinical contraindications, prior failures

Cost Assistance Programs

Sanofi Patient Assistance:

  • Sanofi Patient Connection for uninsured/underinsured patients
  • Income-based eligibility requirements
  • May cover full cost of medication

Copay Assistance:

  • Manufacturer copay cards may reduce out-of-pocket costs
  • Check eligibility restrictions for government insurance

Foundation Grants:

Frequently Asked Questions

How long does Humana prior authorization take in Ohio? Standard prior authorizations are decided within 72 hours for non-urgent requests, 24 hours for expedited cases where delay could jeopardize health.

What if Fabrazyme is not on Humana's formulary? You can request a formulary exception through Humana's standard process. Include medical necessity documentation and prescriber justification for why formulary alternatives are inappropriate.

Can I get an expedited appeal if my Fabrazyme is denied? Yes, if your prescriber determines that a delay in treatment could seriously jeopardize your health. Expedited appeals must be decided within 72 hours.

Does step therapy apply to rare disease medications in Ohio? Ohio law allows step therapy exemptions for rare diseases when clinically justified. Fabry disease qualifies, and you can request an exemption with appropriate documentation.

What happens if I'm switching from another insurer to Humana? Ohio's continuity of care laws require Humana to provide bridge coverage (typically 30 days) while reviewing your case. Submit your current authorization and medical records immediately.

Who can help me navigate the appeals process in Ohio? The Ohio Department of Insurance Consumer Services at 800-686-1526 provides free assistance with health coverage appeals and external reviews.

About Counterforce Health: Counterforce Health helps patients and clinicians navigate complex prior authorization requirements by analyzing denial letters, plan policies, and clinical documentation to create targeted, evidence-backed appeals. The platform streamlines the appeals process for specialty medications like Fabrazyme, turning insurance denials into successful approvals through systematic, data-driven advocacy.

When dealing with Humana denials for Fabrazyme in Ohio, having expert support can make the difference between prolonged delays and rapid approval. Counterforce Health's platform understands payer-specific requirements and helps craft appeals that address each plan's unique criteria and procedural requirements.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and is not medical advice. Always consult with your healthcare provider about your specific medical needs and treatment options. Insurance coverage policies can change; verify current requirements with Humana and consult the Ohio Department of Insurance for the most up-to-date appeals procedures.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.